STERIS plc Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
STERIS plc (STE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$1.60 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-29.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-05-29
- STERIS plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2026 was -$1.60M, a 137.80% decline from fiscal 2025.
- STERIS plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $4.23M, a 30.14% decline from fiscal 2024.
- STERIS plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $6.06M.
- STERIS plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$4.38M, a 141.49% decline from fiscal 2022.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2026-03-31 | -$1.60M 10-K · filed 2026-05-29 |
| 2025-03-31 | $4.23M 10-K · filed 2025-05-29 |
| 2024-03-31 | $6.06M 10-K · filed 2024-05-29 |
| 2023-03-31 | -$4.38M 10-K · filed 2023-05-26 |
| 2022-03-31 | $10.55M 10-K · filed 2022-05-31 |
| 2021-03-31 | $252.00K 10-K · filed 2021-05-28 |
| 2020-03-31 | $413.00K 8-K · filed 2021-02-09 |
| 2019-03-31 | $118.00K 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |